Episode III: Antxon Caballero, Heuristik

Episode 3,   Sep 09, 07:34 PM

Episode image

In this episode of Venture Vitals, Tomas Studenik and Evgeny Shvarov speak with Antxon Caballero, CEO of Heuristik, about doing business with hospitals in EU and U.S., managing healthcare risk, and opportunities in healthcare IT. Antxon also shares insights on scaling startups, securing investment, and the path to becoming a unicorn in health tech.

In the latest episode of Venture Vitals, Tomas Studenik and Evgeny Shvarov sit down with Antxon Caballero, CEO of Heuristik, to explore the complex landscape of doing business with hospitals in Spain, EU as well as U.S. From navigating identity verification issues to managing high-damage claims, Antxon shares valuable insights on mitigating risks in health tech. They also dive deep into opportunities for innovation in healthcare IT systems and the importance of incubation and acceleration programs for startups. Tune in for expert advice on scaling in digital health, securing investor interest, and the steps to becoming the next unicorn in the industry.

Antxon Caballero - CEO, Heuristik
Antxon is a serial entrepreneur with a successful exit. Antxon has international experience in sales and team management, he founded Heuristik after his grandfather almost died because of an identification error.

What is Heuristik?
The WHO says that you have 10% chances of being wrong identified, in Europe over 500M patients suffer identification errors every year with a market cost of over €200B. Clearly the current patient identification solutions are not working and that's why we created Heuristik, Heuristik is a software solution to identify and manage patients combining fingerprints and artificial intelligence. Using Heuristik healthcare entities can identify patients during the whole patient journey using their fingerprint and obtain real time statistics to avoid bottlenecks. See www.heuristik.tech